UK guidelines for the medical and laboratory screening of sperm, egg and embryo donors (2008)

Human Fertility

Volumn 11, Issue 4, 2008, Pages 201-210

  Pacey, Allan ^a  

^a NONE

Author keywords

Donation; Egg; Embryo; Guidelines; Sperm; UK

Indexed keywords

RHESUS ANTIGEN;

ANAMNESIS; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BACTERIAL INFECTION; BACTERIUM DETECTION; BRAIN SPONGIOSIS; CLINICAL PROTOCOL; CYTOMEGALOVIRUS INFECTION; DONOR SELECTION; FAMILY HISTORY; FEMALE; HUMAN; HUMAN EMBRYO; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INFECTION CONTROL; INFECTION RISK; KARYOTYPING; MALE; MEDICAL SOCIETY; NUCLEIC ACID AMPLIFICATION; OOCYTE; PHYSICAL EXAMINATION; SPERM DONOR; UNITED KINGDOM; VIRUS DETECTION; VIRUS TRANSMISSION;

EMBRYO, MAMMALIAN; FEMALE; HUMANS; INSEMINATION, ARTIFICIAL, HETEROLOGOUS; KARYOTYPING; LIVING DONORS; MALE; MEDICAL HISTORY TAKING; OVUM; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; SEMEN PRESERVATION; SPERMATOZOA; TISSUE AND ORGAN PROCUREMENT;

EID: 57749110929     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.1080/14647270802563816     Document Type: Article

References (64)

1. Advisory Committee on Dangerous Pathogens and the Spongiform Encephalopathy Advisory Committee Transmissible (2003) Spongiform encephalopathy agents: Safe working and the prevention of infection.
2. Aird, I., Barratt, C., Murdoch, A. and BFS Committee (2000) BFS recommendations for good practice on the screening of egg and embryo donors. Human Fertility, 3, pp. 162-165.
3. Aitken, R. J. and De Iuliis, G. N. (2007) Value of DNA integrity assays for fertility evaluation. Society of Reproduction and Fertility Supplement, 65, pp. 81-92.
4. Andersen, A-M. N., Wohlfarht, J., Christens, P., Olsen, J. and Melbye, M. (2000) Maternal age and fetal loss. British Medical Journal, 320, pp. 1708-1712.
5. Barratt, C. L., Clements, S. and Kessopoulou, E. (1998) Semen characteristics and fertility tests required for storage of spermatozoa. Human Reproduction, 13, pp. 1-7.
6. Bille, C., Skytthe, A., Vach, W., Knudsen, L. B., Andersen, A. M., Murray, J. C. and Christensen, K. (2005) Parent's age and the risk of oral clefts. Epidemiology, 16, pp. 311-316.
7. Bonde, J. P., Ernst, E., Jensen, T. K., Hjollund, N. H., Kolstad, H., Henriksen, T. B., Scheike, T., Giwercman, A., Olsen, J. and Skakkebaek, N. E. (1998) Relation between semen quality and fertility: A population-based study of 430 first-pregnancy planners. Lancet, 352, pp. 1172-1177.
8. British Andrology Society (1999) Guidelines for the screening of semen donors for donor insemination. Human Reproduction, 14, pp. 1823-1826.
9. British Association for Sexual Health and HIV (2006) Sexually transmitted infections: UK National screening and testing guidelines.
10. British Infertility Counselling Association (2007) BICA Guidelines for good practice in infertility counselling, BICA Publications, Sheffield
11. British Transplantation Society (2000) UK guidelines for living kidney donor transplantation. Joint working party of the BTS and the Renal Association
12. Busch, M. P. and Satten, G. A. (1997) Time course of viraemia and antibody seroconversion following human immunodeficiency virus exposure. American Journal of Medicine, 19, pp. 117-124.
13. Chiavetta, J. A., Escobar, M., Newman, A., He, Y., Driezen, P., Deeks, S., Hone, D., O'Brien, S. and Sher, G. (2003) Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. Canadian Medical Association Journal, 169, pp. 767-773.
14. Cohen, M. A., Lindheim, S. R. and Sauer, M. V. (1999) Donor age is paramount to success in oocyte donation. Human Reproduction, 14, pp. 2755-2758.
15. Crow, J. F. (1997) The high spontaneous mutation rate: Is it a health risk. Proceedings of the National Academy of Sciences of the United States of America, 94, pp. 8380-8386.
16. Cuckle, H. (1999) Maternal age-standardisation of prevalence of Down's syndrome. Lancet, 354, pp. 529-530.
17. Curson, R. and Karakosta, C. (2000) Recruitment of only cytomegalovirus (CMV) negative semen donors. Human Reproduction, 15, p. 2247.
18. De La Rochebrochard, E., McElreavey, K. and Thonneau, P. (2003) Paternal age over 40 years: The 'amber light' in the reproductive life of men. Journal of Andrology, 24, pp. 459-465.
19. DeMarini, D. M. (2004) Genotoxicity of tobacco smoke and tobacco smoke condensate: A review. Mutation Research, 567, pp. 447-474.
20. European Union (2006) Commission Directive 2006/17/EC implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Official Journal of the European Union, p. L 38/40.
21. Evans, J. A., Canning, N. and Hunter, A. G. W. (1978) A cytogenetic survey of 14,069 newborn infants. Cytogenetics and Cell Genetics, 20, pp. 96-123.
22. Expert Advisory Group on AIDS (2007) Public minutes of the meeting on 21st February 2007.
23. Fletcher, N. A. and Marsden, C. D. (1996) Dyskinetic cerebal palsy: A clinical and genetic study. Developmental Medicine and Child Neurology, 38, pp. 873-880.
24. Food and Drug Administration (2004) Eligibility determination for donors of human cells, tissues and cellular and tissue-based products, 21 CFR Parts 210, 211, 820 and 1271. Federal Register, 69, pp. 29786-29794.
25. Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J. and Alford, C. A. (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. New England Journal of Medicine, 326, pp. 663-667.
26. Gazvani, R., Hamilton, M. P., Simpson, S. A. and Templeton, A. (2002) New challenges for gamete donation programmes: Changes in guidelines are needed. Human Fertility, 5, pp. 183-184.
27. Gosden, R. G. (2005) Prospects for oocyte banking and in vitro maturation. Journal of the National Cancer Institute Monographs, 34, pp. 60-63.
28. Griffiths, P. D. (2002) Strategies to prevent CMV infection in the neonate. Seminars in Neonatology, 7, pp. 293-299.
29. Hamer, F. C., Horne, G., Pease, E. H., Matson, P. L. and Lieberman, B. A. (1995) The quarantine of fertilized donated oocytes. Human Reproduction, 10, pp. 1194-1196.
30. Hamilton, M. P. (2008) Working party on sperm donation services in the UK. Human Fertility, 11, pp. 147-158.
31. Hemmings, D. G., Kilani, R., Nykiforuk, C., Preiksaitis, J. and Guilbert, L. J. (1998) Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. Journal of Virology, 72, pp. 4970-4979.
32. HMSO (2004) Human fertilisation and embryology authority disclosure of donor information regulations (2004) statutory instrument 2004 No 1511.
33. Human Fertilisation and Embryology Authority (2005) SEED Report. Human Fertilisation and Embryology Authority, London
34. Human Fertilisation and Embryology Authority (2005) Who are the Donors?. Human Fertilisation and Embryology Authority, London
35. Human Fertilisation and Embryology Authority (2006) A long-term analysis of the HFEA Register data 1991-2005. Human Fertilisation and Embryology Authority, London
36. Irvine, D. S., Twigg, J. P., Gordon, E. L., Fulton, N., Milne, P. A. and Aitken, R. J. (2000) DNA integrity in human spermatozoa: Relationships with semen quality. Journal of Andrology, 21, pp. 33-44.
37. Jain, J. K. and Paulson, R. J. (2006) Oocyte cryopreservation. Fertility and Sterility, 86, pp. 1037-1046.
38. Lau, J. Y. and Wright, T. L. (1993) Molecular virology and pathogenesis of hepatitis B. Lancet, 342, pp. 1335-1340.
39. Liesnard, C., Strebelle, E. and Englert, Y. (2001) Screening standards in assisted reproductive technologies. Is the British Andrology Society recommendation to recruit cytomegalovirus negative semen donors only, a reasonable one?. Human Reproduction, 16, pp. 1789-1791.
40. Liesnard, C. A., Revelard, P. and Englert, Y. (1998) Is matching between women and donors feasible to avoid cytomegalovirus infection in artificial insemination with donor semen. Human Reproduction, 13, pp. 25-31.
41. Mansat, A., Mengelle, C., Chalet, M., Boumzebra, A., Mieusset, R., Puel, J., Prouheze, C. and Segondy, M. (1997) Cytomegalovirus detection in cryopreserved semen samples collected for therapeutic donor insemination. Human Reproduction, 12, pp. 1663-1666.
42. Matson, P. (2001) Screening standards in assisted reproduction technologies: The screening of semen donors - where do we draw the line. Human Reproduction, 16, p. 2039.
43. McPherson, E. (2006) Genetic diagnosis and testing in clinical practice. Clinical Medicine and Research, 4, pp. 123-129.
44. Menken, J., Trussell, J. and Larsen, U. (1986) Age and infertility. Science, 233, pp. 1389-1394.
45. Mirkin, S., Gimeno, T. G., Bovea, C., Stadtmauer, L., Gibbons, W. E. and Oehninger, S. (2003) Factors associated with an optimal pregnancy outcome in an oocyte donation program. Journal of Assisted Reproduction and Genetics, 20, pp. 400-408.
46. National Collaborating Centre for Women's and Children's Health on behalf of National Institute of Clinical Excellence (2004) Fertility: assessment and treatment for people with fertility problems.pp. 104-106. RCOG Press
47. Netski, D. M., Mosbruger, T., Depla, E., Maertens, G., Ray, S. C., Hamilton, R. G., Roundtree, S., Thomas, D. L., McKeating, J. and Cox, A. (2005) Humoral immune response in acute hepatitis C virus infection. Clinical Infectious Diseases, 41, pp. 667-675.
48. Offergeld, R., Faensen, D., Ritter, S. and Hamouda, O. (2005) Human immunodefieciency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: Risk of virus transmission and the impact of nuclei acid amplification testing. Eurosurviellance, 10, pp. 8-11.
49. Pados, G., Camus, M., Van Waesberghe, L., Liebaers, I., Van Steirteghem, A. and Devroey, P. (1992) Oocyte and embryo donation: Evaluation of 412 consecutive trials. Human Reproduction, 7, pp. 1111-1117.
50. Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology (2006) 2006 Guidelines for gamete and embryo donation. Fertility and Sterility, 86, pp. S38-S50.
51. Ratcliff, R. M., Chang, G., Kok, T. and Sloots, T. P. (2007) Molecular diagnosis of medical viruses. Current Issues in Molecular Biology, 9, pp. 87-102.
52. Ravel, C., Berthaut, I., Bresson, J. L., Siffroi, J. P. and Genetics Commission of the French Federation of CECOS. (2006) Prevalence of chromosomal abnormalities in phenotypically normal and fertile adult males: Large-scale survey of over 10,000 sperm donor karyotypes. Human Reproduction, 21, pp. 1484-1489.
53. Raynor, B. D. (1993) Cytomegalovirus infection in pregnancy. Seminars in Perinatology, 17, pp. 394-402.
54. Reichenberg, A., Gross, R., Weiser, M., Bresnahan, M., Silverman, J., Harlap, S., Rabinowitz, J., Shulman, C., Malaspina, D., Lubin, G., Knobler, H. Y., Davidson, M. and Susser, E. (2006) Advancing paternal age and autism. Archives of General Psychiatry, 63, pp. 1026-1032.
55. Seli, E., Gardner, D. K., Schoolcraft, W. B., Moffatt, O. and Sakkas, D. (2004) Extent of nuclear DNA damage in ejaculated spermatozoa impacts on blastocyst development after in vitro fertilization. Fertility and Sterility, 82, pp. 378-383.
56. Shen, C. Y., Chang, S. F., Chao, M. F., Yang, S. L., Lin, G. M., Chang, W. W., Wu, C. W., Yen, M. S., Ng, H. T. Thomas, J. C. et al. (1993) Cytomegalovirus recurrence in seropositive pregnant women attending obstetric clinics. Journal of Medical Virology, 41, pp. 24-29.
57. Simons, E. G. and Ahuja, K. K. (2005) Egg-sharing: An evidence based solution to donor egg shortages. Obstetrics & Gynaecology (London), 7, pp. 112-116.
58. Singh, N. P., Muller, C. H. and Berger, R. E. (2003) Effects of age on DNA double-strand breaks and apoptosis in human sperm. Fertility and Sterility, 80, pp. 1420-1430.
59. Stekler, J. and Collier, A. C. (2004) Primary HIV Infection. Current HIV/ AIDS Reports, 1, pp. 68-73.
60. Tomsu, M., Sharma, V. and Miller, D. (2002) Embryo quality and IVF treatment outcomes may correlate with different sperm comet assay parameters. Human Reproduction, 17, pp. 1856-1862.
61. Wallerstein, R., Jansen, V., Grifo, J. A., Berkeley, A. S., Noyes, N., Licker, J. and Licciardi, F. (1998) Genetic screening of prospective oocyte donors. Fertility and Sterility, 70, pp. 52-55.
62. World Health Organisation (1999) Laboratory manual for the examination of human semen and sperm cervical mucus interaction, Cambridge University Press, Cambridge, UK
63. Worthington, D. (2006) Sickle cell and thalassaemia handbook for laboratories. NHS Sickle Cell and Thalassaemia Screening Programme, p. 59.
64. Zhu, J. L., Madsen, K. M., Vestergaard, M., Olesen, A. V., Basso, O. and Olsen, J. (2005) Paternal age and congenital malformations. Human Reproduction, 20, pp. 3173-3177.